Observed arrival · 2026-11-17
TargetVista keeps drug-target evidence and its gaps in the record
A drug-discovery platform for reviewing target evidence, clinical history, tractability, and molecule-assessment methods.
○Open
⊠Login
$Paid
†Ads
✦Pretty
●Pro
◎Niche
◉Human
⚑Risk
ƒJS
- For
- Drug-discovery teams qualifying biological targets
- Worth noticing
- It separates measured negative results from missing or unqueried evidence instead of encoding both as zero.
Field notes
The homepage describes records assembled per target from primary sources including CIViC, CPIC, Open Targets, ChEMBL, ClinicalTrials.gov, and others, with source and read date attached. Its evidence states separate a finding, a measured negative, and an unestablished lookup; the latter is not rendered as zero. Candidate assessment is presented across AutoDock Vina, Boltz-2 co-folding, and developability filters, with stated pose and ranking constraints.
Observed signals
Read the marks
Editorial observations of this landing page, not a rating.
○OpenPublic substance visible
$PaidCommerce or pricing visible
✦PrettyNotable craft visible
●ProPolished or operationally mature
◎NicheUnusually specific use
ƒJavaScriptBrowser-side code central
One card from the complete issue